VELCADE® Plus Rituximab in Non Hodgkin's Follicular Lymphoma

Clinical trial NCT01830465 · COMPLETED

Trial details

NCT number: NCT01830465
Sponsor: Gruppo Italiano Studio Linfomi
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non Hodgkin's Follicular Lymphoma

Start date: 2006-08-01
Primary completion: 2008-08-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.